$SMG
SCOTTS MIRACLE-GRO CO Stock $smg

$smg Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000154638024000007 Filed on February 07, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$1.525B	$410.4M
YoY Change		-22.07%
Cost Of Revenue	$986.8M	$354.0M
YoY Change		-15.83%
Gross Profit	$538.6M	$62.20M
YoY Change		-41.32%
Gross Profit Margin	35.31%	15.16%
Selling, General & Admin	$178.7M	$114.8M
YoY Change		-10.66%
% of Gross Profit	33.18%	184.57%
Research & Development	$8.200M	$8.400M
YoY Change		-5.62%
% of Gross Profit	1.52%	13.5%
Depreciation & Amortization	$20.10M	$16.10M
YoY Change		-8.0%
% of Gross Profit	3.73%	25.88%
Operating Expenses	$189.5M	$114.8M
YoY Change		-11.01%
Operating Profit	$349.1M	-$47.30M
YoY Change		105.65%
Interest Expense	-$51.10M	$42.80M
YoY Change		-179.11%
% of Operating Profit	-14.64%
Other Income/Expense, Net	-$1.200M	-$1.600M
YoY Change		-200.0%
Pretax Income	$219.8M	-$114.2M
YoY Change		21.1%
Income Tax	$62.30M	-$33.70M
% Of Pretax Income	28.34%
Net Earnings	$157.5M	-$80.50M
YoY Change		24.42%
Net Earnings / Revenue	10.33%	-19.62%
Basic Earnings Per Share	$2.77	-$1.42
Diluted Earnings Per Share	$2.74	-$1.42
COMMON SHARES
Basic Shares Outstanding	56.69M shares	56.55M shares
Diluted Shares Outstanding	57.40M shares	56.70M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$65.10M	$10.40M
YoY Change		-59.38%
Cash & Equivalents	$65.10M	$10.40M
Short-Term Investments
Other Short-Term Assets	$168.8M	$213.8M
YoY Change		-16.97%
Inventory	$824.3M	$1.170B
Prepaid Expenses
Receivables	$876.9M	$287.6M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.935B	$1.681B
YoY Change		-26.87%
LONG-TERM ASSETS
Property, Plant & Equipment	$608.2M	$610.4M
YoY Change		2.97%
Goodwill	$243.9M	$243.9M
YoY Change		-4.09%
Intangibles	$428.9M	$433.2M
YoY Change		-24.79%
Long-Term Investments	$83.80M	$90.80M
YoY Change		-49.97%
Other Assets	$624.3M	$656.4M
YoY Change		4.17%
Total Long-Term Assets	$1.989B	$2.035B
YoY Change		-8.95%
TOTAL ASSETS
Total Short-Term Assets	$1.935B	$1.681B
Total Long-Term Assets	$1.989B	$2.035B
Total Assets	$3.924B	$3.716B
YoY Change		-18.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$440.4M	$332.5M
YoY Change		-9.35%
Accrued Expenses	$75.90M	$77.20M
YoY Change		0.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$57.80M	$54.50M
YoY Change		-74.86%
Total Short-Term Liabilities	$1.060B	$764.1M
YoY Change		-17.99%
LONG-TERM LIABILITIES
Long-Term Debt	$2.761B	$2.969B
YoY Change		-6.92%
Other Long-Term Liabilities	$354.3M	$368.4M
YoY Change		4.3%
Total Long-Term Liabilities	$3.115B	$3.337B
YoY Change		-5.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.060B	$764.1M
Total Long-Term Liabilities	$3.115B	$3.337B
Total Liabilities	$4.175B	$4.102B
YoY Change		-8.34%
SHAREHOLDERS EQUITY
Retained Earnings	$491.8M	$372.4M
YoY Change		-59.43%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$977.8M	$985.7M
YoY Change		-6.72%
Treasury Stock Shares
Shareholders Equity	-$250.9M	-$385.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.924B	$3.716B
YoY Change		-18.04%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	$157.5M	-$80.50M
YoY Change		24.42%
Depreciation, Depletion And Amortization	$20.10M	$16.10M
YoY Change		-8.0%
Cash From Operating Activities	$304.2M	-$343.2M
YoY Change		-20.48%
INVESTING ACTIVITIES
Capital Expenditures	$16.30M	$37.90M
YoY Change		28.04%
Acquisitions
YoY Change
Other Investing Activities	-$1.600M	-$6.100M
YoY Change		-195.31%
Cash From Investing Activities	-$17.90M	-$53.20M
YoY Change		47.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-231.4M	$374.2M
YoY Change		-7.88%
NET CHANGE
Cash From Operating Activities	304.2M	-$343.2M
Cash From Investing Activities	-17.90M	-$53.20M
Cash From Financing Activities	-231.4M	$374.2M
Net Change In Cash	54.90M	-$21.50M
YoY Change		-64.87%
FREE CASH FLOW
Cash From Operating Activities	$304.2M	-$343.2M
Capital Expenditures	$16.30M	$37.90M
Free Cash Flow	$287.9M	-$381.1M
YoY Change		-17.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Supplier Finance Program Obligation Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q4	us-gaap	Supplier Finance Program Obligation Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q3	us-gaap	Supplier Finance Program Obligation Statement Of Financial Position Extensible Enumeration SupplierFinanceProgramObligationStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableCurrent
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	354000000.0	usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	420600000	usd
CY2023Q4	smg	Cost Of Sales Impairment Restructuring And Other Charges CostOfSalesImpairmentRestructuringAndOtherCharges	-5800000	usd
CY2022Q4	smg	Cost Of Sales Impairment Restructuring And Other Charges CostOfSalesImpairmentRestructuringAndOtherCharges	10300000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	62200000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	95700000	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	114800000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	128500000	usd
CY2023Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-7100000	usd
CY2022Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	8500000	usd
CY2023Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1800000	usd
CY2022Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-500000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-47300000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-41800000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-22500000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11400000	usd
CY2023Q4	us-gaap	Interest Expense InterestExpense	42800000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	42700000	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1600000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1600000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-114200000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-94300000	usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-33700000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-29600000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-80500000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-64700000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.42
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56700000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55500000	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56700000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55500000	shares
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-80500000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-64700000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3100000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7200000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-8200000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-4800000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	1500000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	3700000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-900000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-20400000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	-1400000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	-2900000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8900000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24600000	usd
CY2023Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-89400000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-89300000	usd
CY2023Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	200000	usd
CY2022Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	3900000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	16000000.0	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	20900000	usd
CY2023Q4	us-gaap	Depreciation Depreciation	16100000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	17500000	usd
CY2023Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	4000000.0	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7700000	usd
CY2023Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-7100000	usd
CY2022Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23100000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-22500000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-11400000	usd
CY2023Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-200000	usd
CY2022Q4	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	0	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18200000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	108400000	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	286300000	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	177200000	usd
CY2023Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	40800000	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	67000000.0	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	83600000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-44700000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-81800000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-53500000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	7600000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	2800000	usd
CY2023Q4	smg	Increase Decrease In Other Net IncreaseDecreaseInOtherNet	-500000	usd
CY2022Q4	smg	Increase Decrease In Other Net IncreaseDecreaseInOtherNet	-2200000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-343200000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-431600000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37900000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29600000	usd
CY2023Q4	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	21400000	usd
CY2022Q4	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	0	usd
CY2023Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-6100000	usd
CY2022Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	6400000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-53200000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-36000000.0	usd
CY2023Q4	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	444900000	usd
CY2022Q4	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	645600000	usd
CY2023Q4	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	34700000	usd
CY2022Q4	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	202600000	usd
CY2023Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	37400000	usd
CY2022Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	36600000	usd
CY2023Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3100000	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	800000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	500000	usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000	usd
CY2023Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	4000000.0	usd
CY2022Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	374200000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	406200000	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	700000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-21500000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61200000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31900000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	86800000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10400000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	25600000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10400000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25600000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	31900000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15900000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	12000000.0	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	15100000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	287600000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	311400000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	304200000	usd
CY2023Q4	smg	Accounts Receivable Receivables Pledged As Collateral AccountsReceivableReceivablesPledgedAsCollateral	0	usd
CY2022Q4	smg	Accounts Receivable Receivables Pledged As Collateral AccountsReceivableReceivablesPledgedAsCollateral	178900000	usd
CY2023Q3	smg	Accounts Receivable Receivables Pledged As Collateral AccountsReceivableReceivablesPledgedAsCollateral	0	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1169600000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1525900000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	880300000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	213800000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	257500000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	181400000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1681400000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2299300000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	1397800000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	90800000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	181500000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	91900000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	760500000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	780600000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	765400000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	610400000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	592800000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	610300000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	243900000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	254300000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	243900000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	433200000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	576000000.0	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	436700000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	656400000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	630100000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	633100000	usd
CY2023Q4	us-gaap	Assets Assets	3716100000	usd
CY2022Q4	us-gaap	Assets Assets	4534000000	usd
CY2023Q3	us-gaap	Assets Assets	3413700000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	54500000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	216800000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	52300000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	332500000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	366800000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	271200000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	377100000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	348100000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	450200000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	764100000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	931700000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	773700000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2969000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3189600000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2557400000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	368400000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	353200000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	349900000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4101500000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4474500000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	3681000000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56700000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55900000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56500000	shares
CY2023Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	349600000	usd
CY2022Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	367600000	usd
CY2023Q3	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	353100000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	372400000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	917900000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	490900000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	11500000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	12300000	shares
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	11600000	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	985700000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1056700000	usd
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	998500000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-121700000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-169300000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-112800000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-385400000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	59500000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-267300000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3716100000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4534000000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3413700000	usd
CY2023Q4	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
CY2023Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	600000000.0	usd
CY2023Q4	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-140100000	usd
CY2023Q4	us-gaap	Proceeds From Sale Of Other Receivables ProceedsFromSaleOfOtherReceivables	199600000	usd
CY2023Q3	us-gaap	Restructuring Reserve RestructuringReserve	40500000	usd
CY2023Q4	smg	Restructuring And Other Related Charges Continuing Operations RestructuringAndOtherRelatedChargesContinuingOperations	3600000	usd
CY2023Q4	smg	Payments For Restructuring And Other PaymentsForRestructuringAndOther	10100000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	34000000.0	usd
CY2023Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	13800000	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	30800000	usd
CY2022Q4	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	20400000	usd
CY2023Q3	us-gaap	Supplier Finance Program Obligation SupplierFinanceProgramObligation	18300000	usd
CY2023Q4	us-gaap	Supplier Finance Program Obligation Decrease Settlement SupplierFinanceProgramObligationDecreaseSettlement	69800000	usd
CY2022Q4	us-gaap	Supplier Finance Program Obligation Decrease Settlement SupplierFinanceProgramObligationDecreaseSettlement	50500000	usd
CY2023Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8600000	usd
CY2022Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	19200000	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	49600000	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	48800000	usd
CY2023Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800000	usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-23900000	usd
CY2023Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-22500000	usd
CY2022Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-11400000	usd
CY2023Q4	smg	Total Impairment Restructuring And Other Charges Recoveries TotalImpairmentRestructuringAndOtherChargesRecoveries	-12900000	usd
CY2022Q4	smg	Total Impairment Restructuring And Other Charges Recoveries TotalImpairmentRestructuringAndOtherChargesRecoveries	18800000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	770600000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1045000000	usd
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	506200000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	298100000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	360600000	usd
CY2023Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	272500000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	100900000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	120300000	usd
CY2023Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	101600000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1169600000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1525900000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	880300000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3043500000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3427300000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2630600000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	54500000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	216800000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	52300000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2969000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3189600000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2557400000	usd
CY2023Q4	smg	Debt Instrument Covenant Fixed Charge Coverage Ratio DebtInstrumentCovenantFixedChargeCoverageRatio	1.08
CY2022Q4	smg	Accounts Receivable Receivables Pledged As Collateral AccountsReceivableReceivablesPledgedAsCollateral	178900000	usd
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.060
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.052
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-267300000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-80500000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8900000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11700000	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.66
CY2023Q4	us-gaap	Dividends Dividends	38000000.0	usd
CY2023Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3100000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	700000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-385400000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	147700000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-64700000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-24600000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20800000	usd
CY2022Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.66
CY2022Q4	us-gaap	Dividends Dividends	37500000	usd
CY2022Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	800000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	18700000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	59500000	usd
CY2023Q4	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-8800000	usd
CY2023Q4	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	4100000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-4000000.0	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8900000	usd
CY2022Q4	us-gaap	Oci Before Reclassifications Before Tax Attributable To Parent OciBeforeReclassificationsBeforeTaxAttributableToParent	-26000000.0	usd
CY2022Q4	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	8900000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-10300000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-24600000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	16000000.0	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	20900000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2600000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4700000	usd
CY2023Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	500000	usd
CY2022Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	48.79
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	50.59
CY2023Q4	us-gaap	Residual Value Of Leased Asset ResidualValueOfLeasedAsset	5200000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	282600000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	281200000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	262600000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77200000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	76500000	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-80500000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-64700000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56700000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55500000	shares
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.17
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56700000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55500000	shares
CY2023Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q4	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56700000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55500000	shares
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.42
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.17
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56700000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55500000	shares
CY2023Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2023Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.295
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.314
CY2023Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	CONTINGENCIES<div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management regularly evaluates the Company’s contingencies, including various judicial and administrative proceedings and claims arising in the ordinary course of business, including product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. </span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Regulatory Matters</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 30, 2023, the Company had recorded liabilities of $2.6 for environmental actions, the majority of which are for site remediation. The Company believes that the amounts accrued are adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</span></div><div style="margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Other</span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s condensed consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor does it expect the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.</span></div>
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies Gross AccrualForEnvironmentalLossContingenciesGross	2600000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	76400000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	234000000.0	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	216400000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	220100000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	311200000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	292900000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	296500000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14800000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	16400000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	14500000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2100000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1900000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1900000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15200000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	16600000	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15000000.0	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	17300000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	18500000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	16900000	usd
CY2023Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	22000000.0	usd
CY2022Q4	us-gaap	Operating Lease Cost OperatingLeaseCost	22200000	usd
CY2023Q4	us-gaap	Variable Lease Cost VariableLeaseCost	6600000	usd
CY2022Q4	us-gaap	Variable Lease Cost VariableLeaseCost	6500000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	600000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1400000	usd
CY2023Q4	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	200000	usd
CY2022Q4	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	300000	usd
CY2023Q4	smg	Finance Lease Cost FinanceLeaseCost	800000	usd
CY2022Q4	smg	Finance Lease Cost FinanceLeaseCost	1700000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	18200000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	19000000.0	usd
CY2023Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	24300000	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	22200000	usd
CY2023Q4	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	200000	usd
CY2022Q4	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	300000	usd
CY2023Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	500000	usd
CY2022Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1300000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	33500000	usd
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16500000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	800000	usd
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y8M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y10M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.055
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.036
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.045
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.044
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	71000000.0	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	2100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	81400000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2800000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	62500000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	2300000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	38700000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	2000000.0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	29800000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1700000	usd
CY2023Q4	smg	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	81700000	usd
CY2023Q4	smg	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	10200000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	365100000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	21100000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	53900000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3800000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	311200000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	17300000	usd
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	410400000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	526600000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	410400000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	526600000	usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	410400000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	526600000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001546380-24-000007-index-headers.html	Edgar Link	pending
0001546380-24-000007-index.html	Edgar Link	pending
0001546380-24-000007.txt	Edgar Link	pending
0001546380-24-000007-xbrl.zip	Edgar Link	pending
exhibit1010smg20231230.htm	Edgar Link	pending
exhibit108smg20231230.htm	Edgar Link	pending
exhibit109smg20231230.htm	Edgar Link	pending
exhibit21smg20231230.htm	Edgar Link	pending
exhibit22smg20231230.htm	Edgar Link	pending
exhibit311smg20231230.htm	Edgar Link	pending
exhibit312smg20231230.htm	Edgar Link	pending
exhibit32smg20231230.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
smg-20231230.htm	Edgar Link	pending
smg-20231230.xsd	Edgar Link	pending
smg-20231230_cal.xml	Edgar Link	unprocessable
smg-20231230_lab.xml	Edgar Link	unprocessable
smg-20231230_def.xml	Edgar Link	unprocessable
smg-20231230_pre.xml	Edgar Link	unprocessable
smg-20231230_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SMG
SCOTTS MIRACLE-GRO CO Stock $smg

2024 Q1 Form 10-Q Financial Statement

#000154638024000007 Filed on February 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMG SCOTTS MIRACLE-GRO CO Stock $smg

2024 Q1 Form 10-Q Financial Statement

#000154638024000007 Filed on February 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMG
SCOTTS MIRACLE-GRO CO Stock $smg